生物技术与制药领域的最新动态
Evelyn Partners Investment Management Services Ltd Reduces Stock Position in Agilent Technologies, Inc. $A - MarketBeat
Handelsbanken Fonder AB Buys 7,524 Shares of Agilent Technologies, Inc. $A - MarketBeat
Thermo Fisher to Purchase Clario to Enhance Clinical Insights and Accelerate Innovation - The Healthcare Technology Report.
Agilent Technologies Stock (A) Eyeing New Highs Ahead of Earnings – What To Expect - AskTraders.com
Biogen pens I&I deal with new Versant macrocycle developer Dayra Therapeutics
Veeva Announces Expanded Partnership with Roche - Veeva
Agilent Technologies, Inc. $A Shares Sold by Rockefeller Capital Management L.P. - MarketBeat
Legal & General Group Plc Reduces Stake in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Bayer’s stock rallies as next-gen blood thinner beats the odds with Phase 3 win
Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials
Bayer’s experimental blood-thinner notches trial win in stroke prevention
Veeva Announces Expanded Partnership with Roche - Yahoo Finance
Roche Adopts Veeva Vault CRM and Agentic AI in Global Rollout (NYSE: VEEV) - Stock Titan
Veeva Announces Expanded Partnership with Roche - PR Newswire
Craig Crews, Mikael Dolsten raise $32M for Quarry Thera
Bayer’s asundexian hits phase III stroke goal in win for FXIa drugs
Novo’s semaglutide fails in phase III Alzheimer’s trials
Data back spinal injury bid from Nervgen in phase Ib/IIa
Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies